These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 18309235)
1. Fasting and caloric restriction increases mRNA concentrations of novel organic cation transporter-2 and carnitine concentrations in rat tissues. Luci S; Hirche F; Eder K Ann Nutr Metab; 2008; 52(1):58-67. PubMed ID: 18309235 [TBL] [Abstract][Full Text] [Related]
2. Carnitine synthesis and uptake into cells are stimulated by fasting in pigs as a model of nonproliferating species. Ringseis R; Wege N; Wen G; Rauer C; Hirche F; Kluge H; Eder K J Nutr Biochem; 2009 Nov; 20(11):840-7. PubMed ID: 18926685 [TBL] [Abstract][Full Text] [Related]
3. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats. Ringseis R; Pösel S; Hirche F; Eder K Pharmacol Res; 2007 Aug; 56(2):175-83. PubMed ID: 17644405 [TBL] [Abstract][Full Text] [Related]
4. PPAR alpha mediates transcriptional upregulation of novel organic cation transporters-2 and -3 and enzymes involved in hepatic carnitine synthesis. Koch A; König B; Stangl GI; Eder K Exp Biol Med (Maywood); 2008 Mar; 233(3):356-65. PubMed ID: 18296741 [TBL] [Abstract][Full Text] [Related]
5. The role of peroxisome proliferator-activated receptor alpha in transcriptional regulation of novel organic cation transporters. Eder K; Ringseis R Eur J Pharmacol; 2010 Feb; 628(1-3):1-5. PubMed ID: 19941851 [TBL] [Abstract][Full Text] [Related]
6. PPARalpha agonists up-regulate organic cation transporters in rat liver cells. Luci S; Geissler S; König B; Koch A; Stangl GI; Hirche F; Eder K Biochem Biophys Res Commun; 2006 Nov; 350(3):704-8. PubMed ID: 17011512 [TBL] [Abstract][Full Text] [Related]
7. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate increases intestinal carnitine absorption in rats. Ringseis R; Lüdi S; Hirche F; Eder K Pharmacol Res; 2008 Jul; 58(1):58-64. PubMed ID: 18620058 [TBL] [Abstract][Full Text] [Related]
8. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. Wu X; Huang W; Prasad PD; Seth P; Rajan DP; Leibach FH; Chen J; Conway SJ; Ganapathy V J Pharmacol Exp Ther; 1999 Sep; 290(3):1482-92. PubMed ID: 10454528 [TBL] [Abstract][Full Text] [Related]
9. Clofibrate treatment up-regulates novel organic cation transporter (OCTN)-2 in tissues of pigs as a model of non-proliferating species. Ringseis R; Luci S; Spielmann J; Kluge H; Fischer M; Geissler S; Wen G; Hirche F; Eder K Eur J Pharmacol; 2008 Mar; 583(1):11-7. PubMed ID: 18258227 [TBL] [Abstract][Full Text] [Related]
10. Short communication: the pharmacological peroxisome proliferator-activated receptor α agonist WY-14,643 increases expression of novel organic cation transporter 2 and carnitine uptake in bovine kidney cells. Zhou X; Wen G; Ringseis R; Eder K J Dairy Sci; 2014; 97(1):345-9. PubMed ID: 24210485 [TBL] [Abstract][Full Text] [Related]
11. Dietary oxidised fat up regulates the expression of organic cation transporters in liver and small intestine and alters carnitine concentrations in liver, muscle and plasma of rats. Koch A; König B; Luci S; Stangl GI; Eder K Br J Nutr; 2007 Nov; 98(5):882-9. PubMed ID: 17524183 [TBL] [Abstract][Full Text] [Related]
12. Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes. Inazu M; Takeda H; Maehara K; Miyashita K; Tomoda A; Matsumiya T J Neurochem; 2006 Apr; 97(2):424-34. PubMed ID: 16539668 [TBL] [Abstract][Full Text] [Related]
13. [Effects of fenofibrate on gene expression of carnitine palmitoyltransferase 1 in liver and skeletal muscle and its influence on insulin sensitivity]. Bai XP; Li HL; Yang WY; Xiao JZ; Wang B; Du RQ; Lou DJ Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):268-70. PubMed ID: 18361841 [TBL] [Abstract][Full Text] [Related]
14. Induction of intestinal peptide transporter 1 expression during fasting is mediated via peroxisome proliferator-activated receptor alpha. Shimakura J; Terada T; Saito H; Katsura T; Inui K Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G851-6. PubMed ID: 16751172 [TBL] [Abstract][Full Text] [Related]
15. Expression and localization of carnitine/organic cation transporter OCTN1 and OCTN2 in ocular epithelium. Garrett Q; Xu S; Simmons PA; Vehige J; Flanagan JL; Willcox MD Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4844-9. PubMed ID: 18641280 [TBL] [Abstract][Full Text] [Related]
16. Ontogeny of Na(+)/L-carnitine transporter and of gamma-trimethylaminobutyraldehyde dehydrogenase and gamma-butyrobetaine hydroxylase genes expression in rat kidney. García-Delgado M; Peral MJ; Durán JM; García-Miranda P; Calonge ML; Ilundáin AA Mech Ageing Dev; 2009 Apr; 130(4):227-33. PubMed ID: 19150623 [TBL] [Abstract][Full Text] [Related]
17. The effects of exercise training on γ-butyrobetaine hydroxylase and novel organic cation transporter-2 gene expression in the rat. Broderick TL; El Midaoui A; Chiasson JL; Wang D; Jankowski M; Gutkowska J Appl Physiol Nutr Metab; 2011 Dec; 36(6):781-9. PubMed ID: 22014179 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of gene expression of heart fatty acid binding protein and organic cation/carnitine transporter in doxorubicin cardiomyopathic rat model. Sayed-Ahmed MM; Al-Shabanah OA; Hafez MM; Aleisa AM; Al-Rejaie SS Eur J Pharmacol; 2010 Aug; 640(1-3):143-9. PubMed ID: 20470772 [TBL] [Abstract][Full Text] [Related]
19. Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood-brain barrier. Miecz D; Januszewicz E; Czeredys M; Hinton BT; Berezowski V; Cecchelli R; Nałecz KA J Neurochem; 2008 Jan; 104(1):113-23. PubMed ID: 17995936 [TBL] [Abstract][Full Text] [Related]
20. Mouse OCTN2 is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha) via a PPRE located in the first intron. Wen G; Ringseis R; Eder K Biochem Pharmacol; 2010 Mar; 79(5):768-76. PubMed ID: 19819229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]